Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation

• Autor(a) principal: Michael Ruberson Ribeiroda Silva
• Data de Publicação: 2019
• Outros Autores: Jéssica Barreto Ribeiro Dos Santos, Alessandra Maciel Almeida, Juliana Alvares Teodoro, Adriana Maria Kakehasi, Francisco de Assis Acurcio
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da UFMG
• Texto Completo: http://hdl.handle.net/1843/56586; https://orcid.org/0000-0003-2550-7249; https://orcid.org/0000-0002-5528-0658; https://orcid.org/0000-0003-0138-9401; https://orcid.org/0000-0002-0210-0721; https://orcid.org/0000-0001-9411-7493; https://orcid.org/0000-0002-5880-5261
• topic: Psoriatic arthritis; Antirheumatic agents; Health policy; Pharmaceutical services; Artrite; Agentes anti-reumaticos; Serviços farmaceuticos

Background: Pharmaceutical Assistance (PA) is a dynamic and multidisciplinary process that aims to supply health systems, programs or services with quality medicines, enabling access and health care, in an efficient and timely manner. The objective of the study was to evaluate the profile of administrative processes for the treatment of PsA, identify the time elapsed in the flow of processes and its associated factors. Methods: A cross-sectional study of medication requests for the treatment of PsA was carried out between November 2014 and December 2016. Linear regression was used to verify the factors associated with time to delivery. Results: A total of 218 cases containing 250 drugs were analyzed. The median time between the medical appointment and the first dispensation was 66days (interquartile range, 44–90). The State proceedings, which includes requesting the drug until the authorization of treatment, was the stage that most contributed to the total time spent. The factors associated with the longer time to delivery of medications were prescriptions coming from clinics and specialty centers, from dermatologists, non-authorized processes and non-persistent patients in the treatment in 12months. Conclusion: The median time to receive medicines for the PsA treatment in Belo Horizonte health region after a medical prescription was higher than 2 months. The time between the solicitation of the medicines and the authorization of the treatment in the SUS (State administrative procedure) was the main component of the total time spent.